Medtronic (MDT) Liabilities and Shareholders Equity (2014 - 2026)

Medtronic (MDT) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $93.0 billion in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 1.47% year-over-year to $93.0 billion; the trailing twelve-month figure through Apr 2026 stood at $366.8 billion (up 1.49% YoY), and the FY2026 full-year result was $93.0 billion, up 1.47% from the prior year.
• Liabilities and Shareholders Equity improved to $93.0 billion in Q2 2026, from $91.5 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $94.1 billion in Q1 2023 to a low of $89.7 billion in Q3 2024.
• A 5-year average of $91.2 billion and a median of $91.0 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity dropped 5.62% in 2022 and grew 2.54% in 2023, its largest moves.
• Tracing MDT's Liabilities and Shareholders Equity over 5 years: stood at $93.2 billion in 2022, then slipped by 3.38% to $90.1 billion in 2023, then declined by 0.05% to $90.0 billion in 2024, then gained by 1.45% to $91.3 billion in 2025, then gained by 1.84% to $93.0 billion in 2026.
• Business Quant data shows MDT's Liabilities and Shareholders Equity at $93.0 billion in Q2 2026, $91.5 billion in Q1 2026, and $91.3 billion in Q4 2025.